|
1.
|
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naive chronic lymphocytic leukemia: a phase 2 study. MedStar authors:
Year: 2021
Citation: - Leukemia & Lymphoma. 62(8):1816-1827, 2021 08.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ahn IE, Desai S, Drinkwater DC, Farooqui MZ, Gaglione EM, Herman SEM, Hughes TE, Lindorfer MA, Lotter J, Maric I, Marti GE, Mo C, Nichols C, Nierman P, Pleyer C, Soto S, Stetler-Stevenson M, Sun C, Superata J, Taylor RP, Tian X, Valdez J, Wake L, Wiestner A, Yuan CM
|
|
2.
|
Single-Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B-Cell Lymphoma. MedStar authors:
- Baez-Sosa, Valentina
- Chaturvedi, Mansi
- Desai, Sanjal
- Hameed, Rumaisa
- Shenoy, Aarthi G
Year: 2021
Citation: - Oncologist. 26(9):e1660-e1663, 2021 09.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Hematology/Oncology Fellowship
- Internal Medicine Residency
Medline publication type:
All authors: - Baez-Sosa V, Chaturvedi M, Desai S, Hameed R, Shenoy AG
|